CoChat
Sign Up
Cited by 168Bacterial Infections and VaccinesMicrobial infections and disease researchBacterial Identification and Susceptibility Testing

Meningococcal C conjugate vaccine: the experience in England and Wales

Campbell, Helen, Borrow, Ray, Salisbury, David, Miller, Elizabeth·2009·Vaccine
DOI 10.1016/j.vaccine.2009.04.067
Open this paper in CoChat — free account

Abstract

Meningococcal C conjugate vaccine was introduced in the UK in November 1999 together with a comprehensive meningococcal surveillance strategy to support and inform the vaccine programme. These surveillance data have provided important information on the long-term effectiveness of the programme, through direct and indirect protection, and on the prevalent serotypes and serosubtypes causing invasive meningococcal infection subsequent to vaccine introduction. The MCC immunization programme has been extremely successful in controlling serogroup C disease and continues to be evaluated. The aim of this paper is to review the experiences in England and Wales over the past 9 years.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2009.04.067

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 81 · Cited by 168

Authors
Campbell, H., Borrow, R., Salisbury, D., & Miller, E.
Affiliations
Manchester Royal Infirmary (GB)
Corresponding author
Campbell, Helen
ORCID
Venue
Vaccine
Publisher
Elsevier BV
Published
2009-06
Volume
27
Pages
B20-B29
ISSN
0264-410X (ISSN-L)
DOI
10.1016/j.vaccine.2009.04.067
OpenAlex
W2049865589
Cited by
168
References
81
Citations by year
2026: 5 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 5 · 2016: 16 · 2015: 20 · 2014: 14 · 2013: 8 · 2012: 16
FWCI
2.09
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Vaccine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
Keywords
meningococcal C vaccine, serogroup C meningococcal disease, meningococcal surveillance, vaccine effectiveness, serotype distribution, immunization programs, England and Wales
MeSH terms
England, Humans, Meningitis, Meningococcal, Population Surveillance, Wales, Meningococcal Vaccines, Neisseria meningitidis, Serogroup C

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review